Castleman disease (CD) is a rare and potentially life-threatening disease. Like so many rare diseases, it is often misdiagnosed, or goes undiagnosed. On Rare Disease Day, EUSA Pharma’s Jon Morgan, VP global head of Medical, discusses the need to bring a new focus to rare diseases like CD
If we want to beat COVID-19, vaccination must be an urgent global effort
A look at the benefits of using cardboard packaging in the transport of vaccines
Success is usually not a linear process – home treatments for COVID-19, in tandem with an effective vaccine, could place a large dent into this pandemic
Is the general public still in the dark on the science of COVID?
What lies ahead for pharmaceutical innovation?
The role of smart technology in improving the wellbeing of doctors and pharmacists
To mark World Cancer Day, Sandoz’ Professor Michael Wiechmann outlines the impact of the pandemic on cancer patients
22% of Brits are buying OTC medicines online after self-diagnosing via the internet
By investing in new tech platforms CDMOs can dramatically increase efficiency in process development and manufacture of ever-more complex therapeutics
COVID-19 threw pharma’s performance on access to medicine into the spotlight. Has the industry passed the test?
Where we might see growth drive innovation in the healthcare industry amid COVID-19 and beyond
Could recent legal decisions on Supplementary Protection Certificates (SPCs) prove to be a hammer blow for the pharma industry?
Dose adjustment based on a patient’s renal function is a very current example of personalising therapy. While this kind of precision medicine holds great potential, it is often overlooked, particularly in younger patients. Darcie Streetman and Rachel Eyler explore the growing knowledge and tools available for optimising renal dosing.
Improving standards of care nationwide with edge computing
